3 Reasons Why Collegium Pharmaceutical (COLL) Is a Great Growth StockZacks Investment Research • 03/13/24
Are You Looking for a Top Momentum Pick? Why Collegium Pharmaceutical (COLL) is a Great ChoiceZacks Investment Research • 03/01/24
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q4 EarningsZacks Investment Research • 02/23/24
Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024GlobeNewsWire • 02/08/24
Why Collegium Pharmaceutical (COLL) Could Beat Earnings Estimates AgainZacks Investment Research • 01/24/24
Strength Seen in Collegium Pharmaceutical (COLL): Can Its 8.4% Jump Turn into More Strength?Zacks Investment Research • 01/04/24
Collegium Pharmaceutical (COLL) Reports Next Week: Wall Street Expects Earnings GrowthZacks Investment Research • 10/31/23
Collegium Announces Extension of Nucynta Regulatory Exclusivity through July 2026GlobeNewsWire • 08/24/23
Here's What Key Metrics Tell Us About Collegium Pharmaceutical (COLL) Q2 EarningsZacks Investment Research • 08/04/23